The Effect of Estrogen Deficiency on Receptor Activator of Nuclear Factor Kappa B Ligand and Osteoprotegerin Synthesis in Periapical Lesions Induced in Rats

Journal of Endodontics

Volumn 33, Issue 9, 2007, Pages 1053-1056

  Zhang, Xiaolei ^a   Peng, Bin ^b   Fan, Mingwen ^b   Bian, Zhuan ^b   Chen, Zhi ^b  

^a TONGJI UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Estrogen; OPG; periapical lesion; RANKL

Indexed keywords

ESTROGEN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; CYTOLOGY; FEMALE; METABOLISM; OSTEOCLAST; RAT; SPRAGUE DAWLEY RAT; TOOTH PERIAPICAL DISEASE;

ANIMALS; ESTROGENS; FEMALE; OSTEOCLASTS; OSTEOPROTEGERIN; PERIAPICAL DISEASES; RANK LIGAND; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34547931667     PISSN: 00992399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joen.2007.04.005     Document Type: Article

References (27)

1. Kong Y.Y., Feige U., Sarosi I., et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402 (1999) 304-308
2. Suda T., Takahashi N., Udagawa N., et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20 (1999) 345-357
3. Takayanagi H., Ogasawara K., Hida S., et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408 (2000) 600-605
4. Simonet W.S., Lacey D.L., Dunstan C.R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 (1997) 309-319
5. Marsden J. The menopause, hormone replacement therapy and breast cancer. J Steroid Biochem Mol Biol 83 (2002) 123-132
6. Srivastava S., Toraldo G., Weitzmann M.N., et al. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J Biol Chem 276 (2001) 8836-8840
7. Kawamoto S., Ejiri S., Nagaoka E., et al. Effects of oestrogen deficiency on osteoclastogenesis in the rat periodontium. Arch Oral Biol 47 (2002) 67-73
8. Gilles J.A., Carnes D.L., Dallas M.R., et al. Oral bone loss is increased in ovariectomized rats. J Endod 23 (1997) 419-422
9. Zhang X., and Peng B. Immunolocalization of receptor activator of NF kappa B ligand in rat periapical lesions. J Endod 31 (2005) 574-577
10. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34 (1982) 285-290
11. Ogawa S., Fujita M., Ishii Y., et al. Impaired estrogen sensitivity in bone by inhibiting both estrogen receptor alpha and beta pathway. J Biol Chem 14 (2000) 21372-21379
12. Bellino F.L. Non-primate animal models of menopause: workshop report. Menopause 7 (2000) 14-24
13. Wronski T.J., Lowry P.L., Walsh C.C., et al. Skeletal alterations in ovariectomized rats. Calcif Tissue Int 37 (1985) 324-328
14. Yamaura M., Nakamura T., Tsurukami H., et al. Local bone turnover in the metaphysic of the proximal tibia and the lumbar vertebra during the early periods after ovariectomy in rats. Calcif Tissue Int 58 (1996) 52-59
15. Horowitz M.C. Cytokines and estrogen in bone: anti-osteoporotic effects. Science 260 (1993) 626-627
16. Fiorelli G., and Brandi M.L. Skeletal effects of estrogens. J Endocrinol Invest 22 (1999) 589-593
17. Hofbauer L.C., Khosla S., Dunstan C.R., et al. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 140 (1999) 4367-4370
18. Spelsberg T.C., Subramaniam M., Riggs B.L., et al. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol 13 (1999) 819-828
19. von Wowern N., and Stoltze K. Comparative bone morphometric analysis of mandibles and 2nd metacarpals. Scand J Dent Res 2 (1979) 358-364
20. von Wowern N. Micrographic and histomorphometric indices of mandibles for diagnosis of osteopenia. Scand J Dent Res 23 (1981) 47-63
21. Kribbs P.J. Oral findings in osteoporosis. Part 2. Relationship between residual ridge and alveolar bone resorption and generalized skeletal osteopenia. J Prosthet Dent 50 (1983) 719-724
22. Nishimura I., Hosokawa R., and Atwood D.A. The knife-edge tendency in mandibular residual ridges in women. J Prosthet Dent 67 (1992) 820-826
23. Elovic R.P. Ovariectomy decreased the bone area fraction of the rat mandible. Calcif Tissue Int 56 (1995) 305-310
24. Tanaka M., Ejiri S., Nakajima M., et al. Changes of cancellous bone mass in rat mandibular condyle following ovariectomy. Bone 25 (1999) 339-347
25. Hofbauer L.C., Khosla S., Dunstan C.R., et al. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15 (2000) 2-12
26. Bucay N., Sarosi I., Dunstan C.R., et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12 (1998) 1260-1268
27. Miyazaki T., Matsunaga T., Miyazaki S., et al. Changes in receptor activator of nuclear factor-kappaB, and its ligand, osteoprotegerin, bone-type alkaline phosphatase, and tartrate-resistant acid phosphatase in ovariectomized rats. J Cell Biochem 93 (2004) 503-512